Helmed by Roche alums, Newleos Therapeutics is taking over four drugs dropped from the Swiss pharma’s pipeline in early 2024.

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

A recent study published in the Journal of Psychopharmacology has offered encouraging preliminary findings for individuals with severe obsessive-compulsive disorder who have not responded to standard ...

Eric Amavizca-Ayala came to the United States as a small child and has two brothers living in Manteca who are United States ...

The University of Birmingham’s first-of-its-kind analysis of 111 studies from 25 nations reveals that psychiatric patients are traumatized and abused.

Authors Table of Contents Media Contact For general and media inquiries and to book our experts, please contact: [email protected] Harm reduction directly empowers people who use drugs to stay safer and ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

In the early hours of September 14, 2021, three men parked in a quiet car park in the southern English market town of ...

A good night's sleep often sets the stage for a positive day. But for the nearly quarter of American adults struggling with ...

We are collecting data on people who have sought ibogaine treatment all around the world so we can start to collect a very ...

The FDA approved 16 psychiatric drugs over the last decade, most of which shared similar mechanisms of action with previously ...